Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts.
The pregnane X receptor (PXR) regulates the metabolism and elimination of bile salts, steroids, and xenobiotics. The sequence of the PXR ligand-binding domain diverges extensively between different animals, suggesting interspecies differences in ligands. Of the endogenous ligands known to activate PXR, biliary bile salts vary the most across vertebrate species, ranging from 27-carbon (C27) bile alcohol sulfates (early fish, amphibians) to C24 bile acids (birds, mammals). Using a luciferase-based reporter assay, human PXR was activated by a wide variety of bile salts. In contrast, zebrafish PXR was activated efficiently only by cyprinol sulfate, the major zebrafish bile salt, but not by recent bile acids. Chicken, mouse, rat, and rabbit PXRs were all activated by species-specific bile acids and by early fish bile alcohol sulfates. In addition, phylogenetic analysis using maximum likelihood demonstrated evidence for nonneutral evolution of the PXR ligand-binding domain. PXR activation by bile salts has expanded from narrow specificity for C27 bile alcohol sulfates (early fish) to a broader specificity for recent bile acids (birds, mammals). PXR specificity for bile salts has thus paralleled the increasing complexity of the bile salt synthetic pathway during vertebrate evolution, an unusual example of ligand-receptor coevolution in the nuclear hormone receptor superfamily.
Krasowski
Matthew D
MD
University of Pittsburgh, Department of Pathology, 200 Lothrop, Pittsburgh, PA 15213, USA. kra3@uchicago.edum
Yasuda
Kazuto
K
Hagey
Lee R
LR
Schuetz
Erin G
EG
D000818:Animals; D001647:Bile Acids and Salts / Q000737:chemistry / Q000494:pharmacology* / Q000502:physiology; D002777:Cholestanols / Q000494:pharmacology; D019143:Evolution, Molecular; D006801:Humans; D051379:Mice; D015394:Molecular Structure; D010802:Phylogeny; D000077297:Pregnane X Receptor; D011817:Rabbits; D051381:Rats; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists* / Q000145:classification* / Q000187:drug effects / Q000235:genetics; D011987:Receptors, Steroid / Q000819:agonists* / Q000145:classification* / Q000235:genetics; D013045:Species Specificity; D029867:Xenopus Proteins / Q000187:drug effects; D014982:Xenopus laevis; D015027:Zebrafish
D001647:Bile Acids and Salts; D002777:Cholestanols; D000077297:Pregnane X Receptor; D018160:Receptors, Cytoplasmic and Nuclear; D011987:Receptors, Steroid; D029867:Xenopus Proteins; C112210:benzoate X receptor, Xenopus; C009561:3,7,12-trihydroxycoprostane
Biochim Biophys Acta. 1969 Jan 21;176(1):204-7
5766020
Biol Pharm Bull. 2002 Oct;25(10):1381-4
12392101
Chem Pharm Bull (Tokyo). 1984 Jul;32(7):2874-7
6499098
Genetics. 2000 May;155(1):431-49
10790415
Mol Endocrinol. 2000 Jan;14(1):27-39
10628745
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):833-8
12569201
Mol Pharmacol. 2004 May;65(5):1159-71
15102944
Comp Biochem Physiol C Toxicol Pharmacol. 2002 Jan;131(1):1-8
11796320
Drug Metab Dispos. 2003 Nov;31(11):1296-9
14570758
Hiroshima J Med Sci. 1994 Jun;43(2):37-67
7928396
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10769-74
11005856
Clin Chim Acta. 2001 Dec;314(1-2):101-6
11718684
J Biol Chem. 2004 Nov 19;279(47):49517-22
15358766
Trends Ecol Evol. 2000 Dec 1;15(12):496-503
11114436
Genes Dev. 1998 May 1;12(9):1269-77
9573044
J Biol Chem. 2000 May 19;275(20):15122-7
10748001
Nucl Recept. 2004 Oct 12;2(1):7
15479477
J Biol Chem. 1991 Apr 25;266(12):7779-83
2019602
Clin Chim Acta. 1996 Jul 30;251(2):173-86
8862472
Am J Kidney Dis. 2003 Jan;41(1):220-4
12500240
Gastroenterology. 1975 Jul;69(1):77-82
1150037
Med Sci Monit. 2003 Mar;9(3):MT21-31
12640349
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12208-13
9770465
Gastroenterology. 1999 Sep;117(3):696-705
10464147
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3369-74
11248085
Pflugers Arch. 2004 Feb;447(5):566-70
12851823
Mol Pharmacol. 2002 Sep;62(3):638-46
12181440
Mol Biol Evol. 2002 Jun;19(6):908-17
12032247
Acta Paediatr. 1999 Oct;88(10):1078-82
10565453
J Lipid Res. 1993 Oct;34(10):1661-74
8245717
Am J Ther. 2002 Sep-Oct;9(5):425-30
12237735
Hepatology. 2000 Jun;31(6):1305-12
10827156
Science. 2003 Dec 12;302(5652):1960-3
14671302
J Clin Invest. 1998 Sep 1;102(5):1016-23
9727070
J Clin Invest. 1957 Apr;36(4):538-42
13416382
Genome Res. 2004 Apr;14(4):580-90
15059999
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3375-80
11248086
Shock. 2003 May;19(5):440-7
12744487
Drug Metab Dispos. 2001 Nov;29(11):1467-72
11602523
Science. 2002 May 17;296(5571):1313-6
12016314
Drug Metab Rev. 2004 Oct;36(3-4):703-22
15554243
Annu Rev Biochem. 2003;72:137-74
12543708
Curr Opin Drug Discov Devel. 2002 Jan;5(1):150-8
11865669
Mol Biol Evol. 1998 May;15(5):568-73
9580986
J Lipid Res. 2003 Sep;44(9):1643-51
12810826
Nucleic Acids Res. 2003 Jul 15;31(14):4051-8
12853622
Nature. 1998 Sep 10;395(6698):137-43
9744270
Endocrinology. 2003 Jun;144(6):2704-16
12746335
J Biol Chem. 2003 Nov 14;278(46):45062-71
12923173
Pharmacogenetics. 2001 Oct;11(7):555-72
11668216
Mol Biol Evol. 2004 Oct;21(10):1923-37
15229292
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5671-6
11331759
Comput Appl Biosci. 1997 Oct;13(5):555-6
9367129
Science. 2002 Dec 13;298(5601):2157-67
12481130
Science. 2001 Jun 22;292(5525):2329-33
11408620
Biochemistry. 2003 Feb 18;42(6):1430-8
12578355
Mol Biol Evol. 2001 Aug;18(8):1585-92
11470850
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):223-8
12509506
J Biol Chem. 2002 Nov 15;277(46):43691-7
12198127
Biochem J. 1969 Sep;114(2):179-84
5810077
Science. 2003 Sep 19;301(5640):1714-7
14500980
Res Vet Sci. 1985 Nov;39(3):378-82
4081345
Mol Endocrinol. 2002 May;16(5):977-86
11981033
Cell. 1998 Jan 9;92(1):73-82
9489701
J Mol Biol. 2003 Aug 22;331(4):815-28
12909012
Genes Dev. 1998 Oct 15;12(20):3195-205
9784494
Nature. 1998 Oct 8;395(6702):612-5
9783588
Biochem J. 1966 Jul;100(1):233-7
5965252
J Biol Chem. 2001 Oct 19;276(42):39411-8
11509573